BCL2L1 and digestive system cancer: Treatment with DMH was very well apparent for progression of colon carcinogenesis, through up-regulated expression for anti-apoptotic (Bcl-2 and Bcl-xl) signals and down-regulated expression for pro-apoptotic (BAX) signals, with more profound effect by taVNS 5.